Research from ESC Heart Failure shows a slower standardized gait speed in older adults with heart failure.
Gait speed significantly declined in patients with heart failure (HF) compared to the general population, according to research published in ESC Heart Failure.
According to the authors, the study is the first to show that gait speed in older adults with HF significantly declined compared with that in the general population, separate from slowness that occurs due to age.
Most prior research defined slowness using a single cut-off value derived from the general population, with no age-specific cut-offs proposed. “As the heart failure population is highly saturated with elderly patients, it is unclear whether older age or heart failure itself contributes the substantial number of patients with heart failure with low gait speed,” the study said.
Data From 3 Studies Examined
The study combined data from 3 different cohorts to determine an event-driven cut-off for the relative decline in gait speed. After excluding patients with a history of cardiovascular disease or missing data, 3777 older adults from the Tokyo Metropolitan Institute of Gerontology-Longitudinal Interdisciplinary Study on Aging (TMIG-LISA) cohort were used to define the standardized gait speed (SGS), which was stratified according to age, sex, and height.
Additionally, 1301 patients from the FRAGILE-HF cohort and 1247 patients from the Kitasato cohort in the same age demographic were used to derive and externally validate, respectively, the SGS ratio cut-off.
The median SGS ratio was slightly, but significantly, higher in the Kitasato cohort (0.74) than the FRAGILE-HF cohort (0.65). In the Kitasato cohort, SGS ratio < 0.527 was associated with a higher 1 year (HR, 1.70; 95% CI, 1.07-2.72, P = 0.024) and long-term (HR, 1.46, 95% CI, 1.05-2.02, P = .024) mortality rate, independent of pre-existing covariates. In both cohorts, the SGS ratio decreased with aging and gait speed declined by 35% to 40%.
Independent from age- and gender-related decline, SGS was observed to be slower in patients age 65 years and older with HF across the 3 separate studies. The study declared a SGS ratio of .527 as a valid cut-off for slowness independently associated with mortality in patients with HF in this age demographic.
“Referring to disease-specific and patient-specific reference values for gait speed would enable healthcare providers to estimate the future risk of adverse events in individual patients with heart failure in clinical practice,” the study said. “This is clinically relevant, as the slowness threshold cannot be the same for a 65-year-old male and a 90-year-old female, which is clearly supported by the present data.” The study also states that future studies should clarify whether interventions increasing gait speed subsequently improve the prognosis.
Reference
Ozawa T, Yamashita M, Seino S, et al. Standardized gait speed ratio in elderly patients with heart failure. ESC Heart Fail. Published online July 10, 2021. doi:10.1002/ehf2.13392
Racial, Ethnic Disparities May Impact Age Differences at First Heart Failure Hospitalization
September 4th 2025Social determinants of health were associated with a younger age of first hospitalization for heart failure in Black and Hispanic patients when compared with Asian and White patients.
Read More
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Patients With HFpEF May Benefit From Accelerated Cardiac Pacing
August 28th 2025In an observational extension of the myPACE clinical trial, researchers found that a personalized accelerated pacing in patients with heart failure with preserved ejection fraction (HFpEF) and a preexisting physiological pacer saw a slower trend in adverse cardiac events and overall improved health status.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Finerenone Demonstrates Safety and Efficacy in Heart Failure When Combined With Diuretics
August 13th 2025Clinical trial results establish the safety and efficacy of finerenone to help preserve potassium levels and reduce sodium in patients on diuretics with heart failure and mildly reduced ejection fraction or preserved ejection fraction.
Read More
Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation
August 13th 2025The cause of dilated cardiomyopathy (DCM) can be associated with the presence of the TTN gene combined with preexisting comorbidities like atrial fibrillation, which increase the odds of developing DCM.
Read More